Back

Adaptive Biotechnologies Quote, Financials, Valuation and Earnings

20 Most Hated Stocks on Wall Street

Click here to see the full list and protect yourself before it's too late.

Sell

ADPT
Adaptive Biotechnologies

Last Price:

2.73

Seasonality Move:

11.32%

7 Day Trial

ALL ACCESS PASS

$ 7

MarketBeat Alert: Strong sell signal just issued for these 20 stocks

Go here now to get free instant access to all 20 stocks to sell.

Adaptive Biotechnologies Price Quote

$2.73

-0.18 (-6.19%)

(Updated: April 16, 2024 at 10:55 AM ET)

Adaptive Biotechnologies Key Stats

Sell

Adaptive Biotechnologies (ADPT) is a Sell

Day range:

$2.88 - $3.11

52-week range:

$2.53 - $9.08

Dividend yield:

P/E ratio:

0.00

P/S ratio:

2.47

P/B ratio:

1.37%

Volume:

2.7M

Avg. volume:

1.8M

1-year change:

-63.21%

Market cap:

$422.2M

Revenue:

$170.3M

EPS:

$-1.56

How Much Does Adaptive Biotechnologies Make?

How Much Are Adaptive Biotechnologies's Sales Annually?
ADPT Revenues are $170.3M
How Much Profit Does Adaptive Biotechnologies's Make A Year?
ADPT net income is -$225.3M

Is Adaptive Biotechnologies Growing As A Company?

What Is Adaptive Biotechnologies's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.17%
What Is Adaptive Biotechnologies's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

Adaptive Biotechnologies Stock Price Performance

Did Adaptive Biotechnologies Stock Go Up Last Month?
Adaptive Biotechnologies share price went down by -10.19% last month
Did ADPT's Share Price Rise Over The Last Year?
ADPT share price fell by -63.21% over the past 1 year

What Is Adaptive Biotechnologies 52-Week High & Low?

What Is Adaptive Biotechnologies’s 52-Week High Share Price?
Adaptive Biotechnologies has traded as high as $9.08 over the past 52 weeks
What Is Adaptive Biotechnologies’s 52-Week Low Share Price?
Adaptive Biotechnologies has traded as low as $2.53 over the past 52 weeks

Adaptive Biotechnologies Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Adaptive Biotechnologies?

How Much Debt Does Adaptive Biotechnologies Have?
Total long term debt quarterly is $0
How Much Cash Does Adaptive Biotechnologies Have?
Cash and short term investments quarterly total is $346.4M
What Is Adaptive Biotechnologies’s Book Value Per Share?
Book value per share is 2.13

Is Adaptive Biotechnologies Cash Flow Positive?

What Is ADPT Cash Flow From Operations?
Cash flow from operations (TTM) is -$156.3M
What Is Adaptive Biotechnologies’s Cash Flow From Financing?
Cash flow from financing (TTM) is $2.2M
What Is Adaptive Biotechnologies’s Cash Flow From Investing?
Cash flow from investing (TTM) is $129.6M

Adaptive Biotechnologies Return On Invested Capital

Is Management Doing A Good Job?
ADPT return on invested capital is -57.64%
What Is Adaptive Biotechnologies Return On Assets?
ROA measures how assets are converting to revenues and is -29.71%
What Is ADPT Return On Equity?
ROE is a measure of profitability and is -57.64%

Adaptive Biotechnologies Earnings Date & Stock Price

What Is Adaptive Biotechnologies's Stock Price Today?
A single share of ADPT can be purchased today for 2.91
What Is Adaptive Biotechnologies’s Stock Symbol?
Adaptive Biotechnologies trades on the nasdaq under the ticker symbol: ADPT
When Is Adaptive Biotechnologies’s Next Earnings Date?
The next quarterly earnings date for Adaptive Biotechnologies is scheduled on May 3, 2024
When Is ADPT's next ex-dividend date?
Adaptive Biotechnologies's next ex-dividend date is June 4, 2020
How To Buy Adaptive Biotechnologies Stock?
You can buy Adaptive Biotechnologies shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Adaptive Biotechnologies Competitors

Who Are Adaptive Biotechnologies's Competitors?
Below is a list of companies who compete with Adaptive Biotechnologies or are related in some way:
- Ampio Pharmaceuticals Inc (AMPE)
- iBio Inc (IBIO)
- NovaBay Pharmaceuticals Inc (NBY)
- Palatin Technologies Inc (PTN)
- Theriva Biologics Inc (TOVX)

Adaptive Biotechnologies Dividend Yield